![Seung-Pyo Hong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seung-Pyo Hong
Corporate Officer/Principal en INFOBANK CORPORATION .
Perfil
Seung-Pyo Hong is currently the Managing Director & Head-iMessage Business at InfoBank Corp.
and the Director at BioActs Co., Ltd.
He completed his undergraduate degree at Kyung Hee University.
Cargos activos de Seung-Pyo Hong
Empresas | Cargo | Inicio |
---|---|---|
INFOBANK CORPORATION | Corporate Officer/Principal | - |
BioActs Co., Ltd.
![]() BioActs Co., Ltd. Medical SpecialtiesHealth Technology BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea. | Director/Miembro de la Junta | - |
Formación de Seung-Pyo Hong.
Kyung Hee University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
INFOBANK CORPORATION | Technology Services |
Empresas privadas | 1 |
---|---|
BioActs Co., Ltd.
![]() BioActs Co., Ltd. Medical SpecialtiesHealth Technology BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Seung-Pyo Hong